Science, Engineering and Translational Research in Cancer Nanotechnology

June 17 - 18, 2017

Chairs

and

Conference Description

The Gordon Research Seminar on Cancer Nanotechnology, held for the first time in 2017, will bring together graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

Cancer nanotechnology is a complex discipline that is fueled by the latest advances in basic chemistry and biology. Translating fundamental science and innovative engineering solutions into new clinical options requires a coordinated effort of diverse group of of researchers. This unique forum will feature outstanding research by early career scientists across the continuum of cancer research.

Related Meeting

This GRS will be held in conjunction with the "Cancer Nanotechnology" Gordon Research Seminar (GRS). Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page for more information.

Conference Program

Saturday
2:00 pm - 5:00 pm	Arrival and Check-in
3:30 pm - 3:45 pm	Introductory Comments by GRC Site Staff / Welcome from the GRS Chair
3:45 pm - 4:30 pm	New Delivery Strategies for Anticancer Therapies Discussion Leader:
3:45 pm - 4:05 pm	"Macrophage-Mediated Gene Delivery to the Tumor Microenvironment"
4:05 pm - 4:10 pm	Discussion
4:10 pm - 4:25 pm	"Protein-Producing Particles for On-Site Drug Delivery"
4:25 pm - 4:30 pm	Discussion
4:30 pm - 6:00 pm	Poster Session
6:00 pm - 7:00 pm	Dinner
7:30 pm - 9:30 pm	New Anticancer Nanomaterials / Keynote Session: Spherical Nucleic Acids as a Powerful New Platform to Develop Cancer Vaccines Discussion Leader:
7:30 pm - 7:50 pm	"Bioorthogonal Triggered Responsive Polymersomes for Anticancer Drug Delivery"
7:50 pm - 8:00 pm	Discussion
8:00 pm - 8:20 pm	"Controlling the Protein Corona of Nanoparticles by Coating Their Surface with Tunable Surfactants"
8:20 pm - 8:30 pm	Discussion
8:30 pm - 9:10 pm	"Spherical Nucleic Acids as a Powerful New Platform to Develop Cancer Vaccines"
9:10 pm - 9:30 pm	Discussion
Sunday
7:30 am - 8:30 am	Breakfast
9:00 am - 11:00 am	Cancer Nanomedicines: From Bench to Clinic Discussion Leader:
9:00 am - 9:20 am	"Radiation Dose Enhancing Nanoparticles: Designing for Efficacy"
9:20 am - 9:30 am	Discussion
9:30 am - 9:50 am	"Development of Robust Asymmetric Field Flow Fractionation Methods for the Comparison of Innovator and Generic Liposomal Nanomedicines in Oncology"
9:50 am - 10:00 am	Discussion
10:00 am - 10:20 am	" Cationic Polymers for Non-Viral Gene Delivery to Primary Human T Cells"
10:20 am - 10:30 am	Discussion
10:30 am - 10:50 am	"Theranostic Barcoded Nanoparticles for Personalized Cancer Medicine"
10:50 am - 11:00 am	Discussion
11:00 am - 12:30 pm	Poster Session Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pm - 1:30 pm	Lunch
1:30 pm - 2:30 pm	Visualization and Modeling of Disease and Treatment Outcomes Discussion Leader:
1:30 pm - 1:50 pm	"Analysis of Nanoparticle Targeting to Solid Tumors"
1:50 pm - 2:00 pm	Discussion
2:00 pm - 2:20 pm	"Contrast Agent Development and Validation for In-Vivo Early Cancer Detection Using Magnetic Relaxometry"
2:20 pm - 2:30 pm	Discussion
2:30 pm - 3:00 pm	Evaluation Period Fill in GRS Evaluation Forms
3:00 pm	Seminar Concludes

Contributors




Support from the Auburn University comes from the College of Sciences and Mathematics and the Department of Chemistry and Biochemistry. The conference also gratefully acknowledges a contribution from the Gomez family.

Conference Links

Conference History Cancer Nanotechnology